Literature DB >> 26626949

Evaluating the relationship between cannabis use and IQ in youth and young adults at clinical high risk of psychosis.

Lisa Buchy1, Larry J Seidman2, Kristin S Cadenhead3, Tyrone D Cannon4, Barbara A Cornblatt5, Thomas H McGlashan6, Diana O Perkins7, William Stone2, Ming T Tsuang3, Elaine F Walker8, Scott W Woods5, Carrie E Bearden9, Daniel H Mathalon10, Jean Addington11.   

Abstract

Among people with psychosis, those with a history of cannabis use show better cognitive performance than those who are cannabis naïve. It is unknown whether this pattern is present in youth at clinical high risk (CHR) of psychosis. We evaluated relationships between IQ and cannabis use while controlling for use of other substances known to impact cognition in 678 CHR and 263 healthy control (HC) participants. IQ was estimated using the Vocabulary and Block Design subtests of the Wechsler Abbreviated Scale of Intelligence. Drug and alcohol use severity and frequency were assessed with the Alcohol and Drug Use Scale, and we inquired participants' age at first use. CHR were further separated into early and late age at onset of cannabis use sub-groups, and low-, moderate- and high-frequency sub-groups. No significant differences in IQ emerged between CHR or HC cannabis users vs. non-users, or between use frequency groups. CHR late-onset users showed significantly higher IQ than CHR early-onset users. Age at onset of cannabis use was significantly and positively correlated with IQ in CHR only. Results suggest that age at onset of cannabis may be a more important factor for IQ than use current use or use frequency in CHR.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Age at onset; Alcohol; Cannabis; IQ; Prodrome; Schizophrenia

Mesh:

Year:  2015        PMID: 26626949      PMCID: PMC5037441          DOI: 10.1016/j.psychres.2015.11.033

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  42 in total

1.  Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.

Authors:  Louise Arseneault; Mary Cannon; Richie Poulton; Robin Murray; Avshalom Caspi; Terrie E Moffitt
Journal:  BMJ       Date:  2002-11-23

2.  The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).

Authors:  Sarah Tosato; Antonio Lasalvia; Chiara Bonetto; Rodolfo Mazzoncini; Doriana Cristofalo; Katia De Santi; Mariaelena Bertani; Sarah Bissoli; Lorenza Lazzarotto; Giovanna Marrella; Dario Lamonaca; Rosanna Riolo; Francesco Gardellin; Anna Urbani; Michele Tansella; Mirella Ruggeri
Journal:  J Psychiatr Res       Date:  2013-01-04       Impact factor: 4.791

3.  Executive functioning in individuals with schizophrenia and/or cocaine dependence.

Authors:  Irina Benaiges; Josep Maria Serra-Grabulosa; Gemma Prat; Ana Adan
Journal:  Hum Psychopharmacol       Date:  2012-11-20       Impact factor: 1.672

4.  Neurocognitive functioning in recently abstinent, cocaine-abusing schizophrenic patients.

Authors:  M R Serper; M L Copersino; D Richarme; N Vadhan; R Cancro
Journal:  J Subst Abuse       Date:  2000

5.  Cannabis use and cognitive functioning in first-episode schizophrenia patients.

Authors:  José Manuel Rodríguez-Sánchez; Rosa Ayesa-Arriola; Ignacio Mata; Teresa Moreno-Calle; Rocío Perez-Iglesias; César González-Blanch; José Antonio Periañez; José Luis Vazquez-Barquero; Benedicto Crespo-Facorro
Journal:  Schizophr Res       Date:  2010-09-09       Impact factor: 4.939

Review 6.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.

Authors:  Theresa H M Moore; Stanley Zammit; Anne Lingford-Hughes; Thomas R E Barnes; Peter B Jones; Margaret Burke; Glyn Lewis
Journal:  Lancet       Date:  2007-07-28       Impact factor: 79.321

7.  The role of cannabis in cognitive functioning of patients with schizophrenia.

Authors:  Thomas Schnell; Dagmar Koethe; Jörg Daumann; Euphrosyne Gouzoulis-Mayfrank
Journal:  Psychopharmacology (Berl)       Date:  2009-03-27       Impact factor: 4.530

8.  Contradictory cognitive capacities among substance-abusing patients with schizophrenia: a meta-analysis.

Authors:  Stéphane Potvin; Christian C Joyal; Julie Pelletier; Emmanuel Stip
Journal:  Schizophr Res       Date:  2007-07-05       Impact factor: 4.939

9.  Cannabis users have higher premorbid IQ than other patients with first onset psychosis.

Authors:  Laura Ferraro; Manuela Russo; Jennifer O'Connor; Benjamin D R Wiffen; Maria Aurora Falcone; Lucia Sideli; Poonam Gardner-Sood; Simona Stilo; Antonella Trotta; Paola Dazzan; Valeria Mondelli; Heather Taylor; Bess Friedman; Hannah Sallis; Caterina La Cascia; Daniele La Barbera; Anthony S David; Abraham Reichenberg; Robin M Murray; Marta Di Forti
Journal:  Schizophr Res       Date:  2013-08-17       Impact factor: 4.939

10.  Cannabis use and cognition in schizophrenia.

Authors:  Else-Marie Løberg; Kenneth Hugdahl
Journal:  Front Hum Neurosci       Date:  2009-11-24       Impact factor: 3.169

View more
  6 in total

1.  Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory.

Authors:  Erin K Kirschmann; Michael W Pollock; Vidhya Nagarajan; Mary M Torregrossa
Journal:  Neuropsychopharmacology       Date:  2016-09-01       Impact factor: 7.853

2.  Comorbid diagnoses for youth at clinical high risk of psychosis.

Authors:  Jean Addington; Danijela Piskulic; Lu Liu; Jonathan Lockwood; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods
Journal:  Schizophr Res       Date:  2017-03-31       Impact factor: 4.939

3.  Association of Fluid Intelligence and Psychiatric Disorders in a Population-Representative Sample of US Adolescents.

Authors:  Katherine M Keyes; Jonathan Platt; Alan S Kaufman; Katie A McLaughlin
Journal:  JAMA Psychiatry       Date:  2017-02-01       Impact factor: 21.596

4.  The impact of a short-term cohousing initiative among schizophrenia patients, high school students, and their social context: A qualitative case study.

Authors:  Domingo Palacios-Ceña; Emilio Andrés Martín-Tejedor; Ana Elías-Elispuru; Amaia Garate-Samaniego; Jorge Pérez-Corrales; Elena García-García
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

5.  Consequences of Adolescent Exposure to the Cannabinoid Receptor Agonist WIN55,212-2 on Working Memory in Female Rats.

Authors:  Erin K Kirschmann; Daniel M McCalley; Caitlyn M Edwards; Mary M Torregrossa
Journal:  Front Behav Neurosci       Date:  2017-07-21       Impact factor: 3.558

6.  Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort.

Authors:  Alexis E Cullen; Jean Addington; Carrie E Bearden; William S Stone; Larry J Seidman; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Scott W Woods; Elaine F Walker
Journal:  Psychoneuroendocrinology       Date:  2020-03-07       Impact factor: 4.905

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.